Dialysis water treated by reverse osmosis decreases the levels of C-reactive protein in uremic patients

Atherosclerosis is a major complication of chronic renal failure. Microinflammation is involved in atherogenesis and is associated with uremia and dialysis. The role of dialysate water contamination in inducing inflammation has been debated. Our aim was to study inflammatory markers in patients on chronic dialysis, before and 3 to 6 months after switching the water purification system from deionization to reverse osmosis. Patients had demographic, clinical and nutritional information collected and blood drawn for determination of albumin, ferritin, C-reactive protein (CRP), interleukin-6, and tumor necrosis factor-alpha in both situations. Acceptable levels of water purity were less than 200 colony-forming units of bacteria and less than 1 ng/ml of endotoxin. Sixteen patients died. They had higher median CRP (26.6 vs 11.2 mg/dl, P = 0.007) and lower median albumin levels (3.1 vs 3.9 g/l, P < 0.05) compared to the 31 survivors. Eight patients were excluded because of obvious inflammatory conditions. From the 23 remaining patients (mean age ± SD: 51.3 ± 13.9 years), 18 had a decrease in CRP after the water treatment system was changed. Overall, median CRP was lower with reverse osmosis than with deionization (13.2 vs 4.5 mg/l, P = 0.022, N = 23). There was no difference in albumin, cytokines, subjective global evaluation, or clinical and biochemical parameters. In conclusion, uremic patients presented a clinically significant reduction in CRP levels when dialysate water purification system switched from deionization to reverse osmosis. It is possible that better water treatments induce less inflammation and eventually less atherosclerosis in hemodialysis patients.

Saved in:
Bibliographic Details
Main Authors: Thomé,F.S., Senger,M., Garcez,C., Garcez,J., Chemello,C., Manfro,R.C.
Format: Digital revista
Language:English
Published: Associação Brasileira de Divulgação Científica 2005
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2005000500018
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-879X2005000500018
record_format ojs
spelling oai:scielo:S0100-879X20050005000182005-05-25Dialysis water treated by reverse osmosis decreases the levels of C-reactive protein in uremic patientsThomé,F.S.Senger,M.Garcez,C.Garcez,J.Chemello,C.Manfro,R.C. Hemodialysis C-reactive protein Dialysate water Reverse osmosi Inflammation Uremia Atherosclerosis is a major complication of chronic renal failure. Microinflammation is involved in atherogenesis and is associated with uremia and dialysis. The role of dialysate water contamination in inducing inflammation has been debated. Our aim was to study inflammatory markers in patients on chronic dialysis, before and 3 to 6 months after switching the water purification system from deionization to reverse osmosis. Patients had demographic, clinical and nutritional information collected and blood drawn for determination of albumin, ferritin, C-reactive protein (CRP), interleukin-6, and tumor necrosis factor-alpha in both situations. Acceptable levels of water purity were less than 200 colony-forming units of bacteria and less than 1 ng/ml of endotoxin. Sixteen patients died. They had higher median CRP (26.6 vs 11.2 mg/dl, P = 0.007) and lower median albumin levels (3.1 vs 3.9 g/l, P < 0.05) compared to the 31 survivors. Eight patients were excluded because of obvious inflammatory conditions. From the 23 remaining patients (mean age ± SD: 51.3 ± 13.9 years), 18 had a decrease in CRP after the water treatment system was changed. Overall, median CRP was lower with reverse osmosis than with deionization (13.2 vs 4.5 mg/l, P = 0.022, N = 23). There was no difference in albumin, cytokines, subjective global evaluation, or clinical and biochemical parameters. In conclusion, uremic patients presented a clinically significant reduction in CRP levels when dialysate water purification system switched from deionization to reverse osmosis. It is possible that better water treatments induce less inflammation and eventually less atherosclerosis in hemodialysis patients.info:eu-repo/semantics/openAccessAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research v.38 n.5 20052005-05-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2005000500018en10.1590/S0100-879X2005000500018
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Thomé,F.S.
Senger,M.
Garcez,C.
Garcez,J.
Chemello,C.
Manfro,R.C.
spellingShingle Thomé,F.S.
Senger,M.
Garcez,C.
Garcez,J.
Chemello,C.
Manfro,R.C.
Dialysis water treated by reverse osmosis decreases the levels of C-reactive protein in uremic patients
author_facet Thomé,F.S.
Senger,M.
Garcez,C.
Garcez,J.
Chemello,C.
Manfro,R.C.
author_sort Thomé,F.S.
title Dialysis water treated by reverse osmosis decreases the levels of C-reactive protein in uremic patients
title_short Dialysis water treated by reverse osmosis decreases the levels of C-reactive protein in uremic patients
title_full Dialysis water treated by reverse osmosis decreases the levels of C-reactive protein in uremic patients
title_fullStr Dialysis water treated by reverse osmosis decreases the levels of C-reactive protein in uremic patients
title_full_unstemmed Dialysis water treated by reverse osmosis decreases the levels of C-reactive protein in uremic patients
title_sort dialysis water treated by reverse osmosis decreases the levels of c-reactive protein in uremic patients
description Atherosclerosis is a major complication of chronic renal failure. Microinflammation is involved in atherogenesis and is associated with uremia and dialysis. The role of dialysate water contamination in inducing inflammation has been debated. Our aim was to study inflammatory markers in patients on chronic dialysis, before and 3 to 6 months after switching the water purification system from deionization to reverse osmosis. Patients had demographic, clinical and nutritional information collected and blood drawn for determination of albumin, ferritin, C-reactive protein (CRP), interleukin-6, and tumor necrosis factor-alpha in both situations. Acceptable levels of water purity were less than 200 colony-forming units of bacteria and less than 1 ng/ml of endotoxin. Sixteen patients died. They had higher median CRP (26.6 vs 11.2 mg/dl, P = 0.007) and lower median albumin levels (3.1 vs 3.9 g/l, P < 0.05) compared to the 31 survivors. Eight patients were excluded because of obvious inflammatory conditions. From the 23 remaining patients (mean age ± SD: 51.3 ± 13.9 years), 18 had a decrease in CRP after the water treatment system was changed. Overall, median CRP was lower with reverse osmosis than with deionization (13.2 vs 4.5 mg/l, P = 0.022, N = 23). There was no difference in albumin, cytokines, subjective global evaluation, or clinical and biochemical parameters. In conclusion, uremic patients presented a clinically significant reduction in CRP levels when dialysate water purification system switched from deionization to reverse osmosis. It is possible that better water treatments induce less inflammation and eventually less atherosclerosis in hemodialysis patients.
publisher Associação Brasileira de Divulgação Científica
publishDate 2005
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2005000500018
work_keys_str_mv AT thomefs dialysiswatertreatedbyreverseosmosisdecreasesthelevelsofcreactiveproteininuremicpatients
AT sengerm dialysiswatertreatedbyreverseosmosisdecreasesthelevelsofcreactiveproteininuremicpatients
AT garcezc dialysiswatertreatedbyreverseosmosisdecreasesthelevelsofcreactiveproteininuremicpatients
AT garcezj dialysiswatertreatedbyreverseosmosisdecreasesthelevelsofcreactiveproteininuremicpatients
AT chemelloc dialysiswatertreatedbyreverseosmosisdecreasesthelevelsofcreactiveproteininuremicpatients
AT manfrorc dialysiswatertreatedbyreverseosmosisdecreasesthelevelsofcreactiveproteininuremicpatients
_version_ 1756391113642475520